{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-childhood/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"0b393c87-257a-567c-b12f-c3d1f55b13aa","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field d2bac2f6-c95c-49e4-8914-529c594c614f --><h2>Update</h2><!-- end field d2bac2f6-c95c-49e4-8914-529c594c614f -->","summary":null,"htmlStringContent":"<!-- begin item 83863796-5b4c-47d8-993a-55ea899bc475 --><!-- end item 83863796-5b4c-47d8-993a-55ea899bc475 -->","topic":{"id":"141a79f8-bf34-5bd6-9d3e-4e2d2e1c98f3","topicId":"884b0998-c242-4b76-869c-7e1d7203ac34","topicName":"Immunizations - childhood","slug":"immunizations-childhood","lastRevised":"Last revised in November 2020","chapters":[{"id":"6ba54a01-de23-5846-8b4d-e24477c75832","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8ca5ebce-3bb6-51f5-897f-9f02d913dd37","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"49b0da44-2af1-559a-aa3d-b7492cc9ee0d","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"69eb6e91-b113-53eb-bd4e-6a2f49ca6593","slug":"changes","fullItemName":"Changes"},{"id":"0b393c87-257a-567c-b12f-c3d1f55b13aa","slug":"update","fullItemName":"Update"}]},{"id":"ea1bc6cb-f5cf-5581-8659-301af7d9fb67","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f586895e-7f2d-51ef-baa8-6a9a1e98695f","slug":"goals","fullItemName":"Goals"},{"id":"1420f7f8-09c4-58fa-8d52-9b4a3d2a8ddf","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"16ddc68d-be0a-56cd-b38a-9acdf13a0bfe","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"713a5cac-cd5d-58d0-8793-b453d244027d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a6ab4abc-1ddb-5864-9f72-3eb58c16089a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b3ef6d84-ce51-57df-ba8a-40fbd3b7ceee","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"e9c4eca9-e338-5ae7-9ad6-cffd74ef6c52","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"9a89a8f0-b573-5292-93a2-1ee7ba24d67e","slug":"the-routine-childhood-immunization-schedule","fullItemName":"The routine childhood immunization schedule"},{"id":"fffdcf61-8f20-593c-9fbc-a4de125dab35","slug":"childhood-immunization-programme-coverage","fullItemName":"Childhood immunization programme coverage"}]},{"id":"e9b881e0-0306-56fc-975a-71fc5731b73a","fullItemName":"Management","slug":"management","subChapters":[{"id":"75d2baa6-d689-537b-985d-3b2b1c30e8b3","slug":"children-up-to-1-year-of-age","fullItemName":"Scenario: Children up to 1 year of age"},{"id":"cb326e70-51cb-5b55-86a4-5d1f28fbcf08","slug":"children-1-2-years-of-age","fullItemName":"Scenario: Children 1-2 years of age"},{"id":"6b4cbafe-fdfb-583a-a3fe-7a96b10253c4","slug":"children-2-10-years-of-age","fullItemName":"Scenario: Children 2-10 years of age"},{"id":"88a19f4f-827e-5331-836f-99c46181a1f9","slug":"children-over-10-years-of-age","fullItemName":"Scenario: Children over 10 years of age"},{"id":"df573b46-28ae-516a-adde-90b8bc742b29","slug":"additional-immunizations","fullItemName":"Scenario: Additional immunizations"}]},{"id":"3a2ea091-53a4-51b4-8c1b-16bbc187300b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"39c5bd91-68df-5d37-bdf6-a3fbf4194d8b","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"e5eea053-f5bc-5745-955b-0200236a454a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"8546e676-a44d-5c1d-a1b9-5d571b466524","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"6b8c8a42-fd07-546b-8ec8-59db2829b422","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"913a73f4-d332-5491-a242-fb9e5fed1e37","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"8e7e3dc1-7bda-57e5-ba9b-f03e0049b730","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"d5fbf31a-ca3a-5b16-86c7-90949cade220","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"49b0da44-2af1-559a-aa3d-b7492cc9ee0d","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"25d1f48f-7b6b-56d0-aabe-4806dc87af51","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field 662d718c-60e6-4a07-b4ce-38ca94622d8d --><h3>New evidence</h3><!-- end field 662d718c-60e6-4a07-b4ce-38ca94622d8d -->","summary":null,"htmlStringContent":"<!-- begin item 34042ec6-2ed4-4c7a-a058-d667b68f906c --><!-- begin field 1782369c-eb6e-40da-93a9-d97c24fb0575 --><h3>Evidence-based guidelines</h3><!-- end field 1782369c-eb6e-40da-93a9-d97c24fb0575 --><!-- begin field 8889309a-3900-414d-8c6e-fe12195bb4c8 --><p>The latest Vaccine update from Public Health England can be found here: <a href=\"https://www.gov.uk/government/collections/vaccine-update\" data-hyperlink-id=\"71d3ff84-6e66-42e1-a551-a8f70153debb\">https://www.gov.uk/government/collections/vaccine-update</a>.</p><ul><li>The SPC for Priorix has been updated to include administration in the deltoid region or in the anterolateral area of the thigh; information about the monovalent or combination vaccines that it can be given with has also been updated. See <a href=\"http://www.medicines.org.uk/emc/medicine/2054\" data-hyperlink-id=\"2fa22644-ece2-44e4-97f6-a8f70153def7\">http://www.medicines.org.uk/emc/medicine/2054</a>.</li><li>NICE (2017)<em> Immunisations: reducing differences in uptake in under 19s.</em> National Institute for Health and Care Excellence. <a href=\"http://www.nice.org.uk/\" data-hyperlink-id=\"169ff3cd-f18d-42bb-9d5e-a8f70153df71\">www.nice.org.uk</a> [<a href=\"https://www.nice.org.uk/guidance/ph21\" data-hyperlink-id=\"b2879ced-43bd-4fd0-bc53-a8f70153df97\">Free Full-text</a>]</li><li>PHE (2017) <em>Contraindications and special considerations: the green book, chapter 6.</em> Public Health England. <a href=\"http://www.gov.uk/\" data-hyperlink-id=\"d5833944-fdb9-424b-a53d-a8f70153df9b\">www.gov.uk</a> [<a href=\"https://www.gov.uk/government/publications/contraindications-and-special-considerations-the-green-book-chapter-6\" data-hyperlink-id=\"9bb6092a-4d47-40db-933b-a8f70153dfa9\">Free Full-text</a>].</li><li>PHE (2017) <em>Hepatitis B: the green book, chapter 18</em>. Public Health England. <a href=\"http://www.gov.uk/\" data-hyperlink-id=\"dbb0ddde-04cf-4a27-96e9-a8f70153dfd0\">www.gov.uk</a> [<a href=\"https://www.gov.uk/government/publications/hepatitis-b-the-green-book-chapter-18\" data-hyperlink-id=\"969bd03e-5848-475d-b589-a8f70153dfd9\">Free Full-text</a>].</li><li>PHE (2017)<em> Hexavalent combination vaccine: programme guidance</em>. Public Health England. <a href=\"http://www.gov.uk/\" data-hyperlink-id=\"9dc1e4dc-e345-4997-ba13-a8f70153dfdd\">www.gov.uk</a> [<a href=\"https://www.gov.uk/government/publications/hexavalent-combination-vaccine-programme-guidance\" data-hyperlink-id=\"8e6b427d-95e4-4f92-83f9-a8f70153e02c\">Free Full-text</a>]</li><li>PHE (2017) <em>Immunisations at one year of age. </em>Public Health England. <a href=\"http://www.gov.uk/\" data-hyperlink-id=\"44523842-cfd0-428a-a3f9-a8f70153e031\">www.gov.uk</a> [<a href=\"https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/623830/IMM_1year_2017.pdf\" data-hyperlink-id=\"2ef317b4-380e-4585-b508-a8f70153e031\">Free Full-text</a>]</li><li>PHE (2017) <em>Vaccine </em><em>update</em><em>: </em><em>issue</em><em> 263, May 2017</em>. Public Health England. <a href=\"http://www.gov.uk/\" data-hyperlink-id=\"312c03ca-c7a4-46bf-9100-a8f70153e06a\">www.gov.uk</a> [<a href=\"https://www.gov.uk/government/publications/vaccine-update-issue-263-may-2017\" data-hyperlink-id=\"243bd031-79af-4c42-b738-a8f70153e073\">Free Full-text</a>]</li><li>PHE (2018) The routine immunisation schedule from spring 2018. <a href=\"http://www.gov.uk/\" data-hyperlink-id=\"dd530995-9793-4d69-a0fd-a8f70153e099\">www.gov.uk</a> [<a href=\"https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/696501/Complete_immunisation_schedule_April2018.pdf\" data-hyperlink-id=\"472f4a2c-3366-4fa1-8185-a8f70153e09d\">Free Full-text</a>]</li><li>EMC (2018) <em>Infanrix </em><em>hexa</em><em>, Powder and suspension for suspension for injection.</em> Electronic Medicines Compendium. <a href=\"https://www.medicines.org.uk/emc/\" data-hyperlink-id=\"b999c496-c45c-4ef3-89a1-a8f70153e0a2\">www.medicines.org.uk</a> [<a href=\"https://www.medicines.org.uk/emc/product/2586/smpc\" data-hyperlink-id=\"84300737-1157-4736-bd2b-a8f70153e109\">Free Full-text</a>] </li><li>PHE (2018) <em>Routine childhood immunisation schedule: Autumn 2018.</em> Public Health England. <a href=\"https://www.gov.uk/\" data-hyperlink-id=\"b4ddab13-560f-4d43-acfc-a967008c659e\">www.gov.uk</a> [<a href=\"https://www.gov.uk/government/publications/routine-childhood-immunisation-schedule\" data-hyperlink-id=\"4f61326c-d5e2-4421-8c49-a967008c65b6\">Free Full-text</a>]</li><li>PHE (2018) <em>Vaccine update 286, September 2018.</em> Public Health England. <a href=\"https://www.gov.uk/\" data-hyperlink-id=\"d3de7e58-5c3f-424c-9bcc-a97000d9323a\">www.gov.uk</a> [<a href=\"https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/744508/VU_286_september_2018.pdf\" data-hyperlink-id=\"efc41896-bfe7-462a-967c-a97000d93246\">Free Full-text</a>]</li><li>PHE (2018) <em>Tetanus: guidance on the management of suspected tetanus cases and on the assessment and management of </em><em>tetanus prone</em><em> wounds.</em> Public Health England. <a href=\"https://www.gov.uk/\" data-hyperlink-id=\"48d89d73-7a30-4950-9afc-a99d0094dc2e\">www.gov.uk</a> [<a href=\"https://www.gov.uk/government/publications/tetanus-advice-for-health-professionals\" data-hyperlink-id=\"a11813ad-6d1b-4509-a7ca-a99d0094dc4a\">Free Full-text</a>]</li><li>PHE (2019) <em>UK immunisation schedule: the green book, chapter 11. </em>Public Health England. <a href=\"https://www.gov.uk/\" data-hyperlink-id=\"26e6fab1-fb98-4196-8298-aa5500d32f9a\">www.gov.uk</a> [<a href=\"https://www.gov.uk/government/publications/immunisation-schedule-the-green-book-chapter-11\" data-hyperlink-id=\"5b9b81bc-ca17-41ed-87a3-aa5500d32fab\">Free Full-text</a>]</li><li>PHE (2019) <em>A guide to immunisations up to one year of age.</em> Public Health England. <a href=\"https://www.gov.uk/\" data-hyperlink-id=\"e01470e7-a9e4-47cb-9374-ab0a00b4d752\">www.gov.uk</a> [<a href=\"https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/844123/PHE_Immunisations_Up_to_one_year_A5_booklet_2019.pdf\" data-hyperlink-id=\"ffdf36cc-2800-4784-a768-ab0a00b4d762\">Free Full-text</a>]</li></ul><!-- end field 8889309a-3900-414d-8c6e-fe12195bb4c8 --><!-- begin field 439f05bf-5744-49c3-973e-506fe6735449 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field 439f05bf-5744-49c3-973e-506fe6735449 --><!-- begin field 1b0a9694-2fe7-40ac-af1d-aa83de9181ff --><p>No new HTAs since 1 June 2016.</p><!-- end field 1b0a9694-2fe7-40ac-af1d-aa83de9181ff --><!-- begin field 4d5466df-d6d9-49ca-a51b-e3cd60aeabf4 --><h3>Economic appraisals</h3><!-- end field 4d5466df-d6d9-49ca-a51b-e3cd60aeabf4 --><!-- begin field f8187767-fe99-4a9e-8974-1e60613bfd72 --><p>No new economic appraisals relevant to England since 1 June 2016.</p><!-- end field f8187767-fe99-4a9e-8974-1e60613bfd72 --><!-- begin field e00d2945-d559-4dfb-a2e5-8bef0d48d738 --><h3>Systematic reviews and meta-analyses</h3><!-- end field e00d2945-d559-4dfb-a2e5-8bef0d48d738 --><!-- begin field 4faa91b2-1bd6-43e5-a3e0-0ebcc3ecd6ee --><ul><li>Beirne, P. V., et al. (2018) <em>Needle size for vaccination procedures in children and adolescents</em>. Cochrane Library. <a href=\"https://www.cochranelibrary.com/\" data-hyperlink-id=\"9b2d4769-651b-4e1f-90ee-a98200adceaa\">www.cochranelibrary.com</a> [<a href=\"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010720.pub3/full\" data-hyperlink-id=\"934f847e-b043-4bb0-af81-a98200adcf4d\">Free Full-text</a>]</li><li>Hviid, A., Hansen, J., Frisch, M., et al. (2019) <em>Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study. </em>Annals of Internal Medicine. <a href=\"https://annals.org/aim\" data-hyperlink-id=\"2bd9d4dc-9af8-465c-a6a6-aa14010054ee\">www.annals.org</a> [<a href=\"https://annals.org/aim/fullarticle/2727726/measles-mumps-rubella-vaccination-autism-nationwide-cohort-study\" data-hyperlink-id=\"28799ed3-ba1e-4a3f-aa97-aa14010055bd\">Free Full-text</a>]</li><li>Di Pietrantonj, C., Rivetti, A., Marchione, P. et al. (2020) Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Library. <a href=\"https://www.cochranelibrary.com/\" data-hyperlink-id=\"1edfb6d1-e085-4012-a320-aba700e2d4bd\">www.cochranelibrary.com</a> [<a href=\"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004407.pub4/full\" data-hyperlink-id=\"18bc456d-7c67-4f3a-b3de-aba700e2d5c5\">Free Full-text</a>]</li></ul><!-- end field 4faa91b2-1bd6-43e5-a3e0-0ebcc3ecd6ee --><!-- begin field 06bcba16-8d82-4ca1-bbe9-029b6e6c2367 --><h3>Primary evidence</h3><!-- end field 06bcba16-8d82-4ca1-bbe9-029b6e6c2367 --><!-- begin field 16995ef2-a2fe-47c0-b0ad-b311cd62a8cc --><ul><li>Davis, K., Pinto, M.V., Andrews, N.J., et al. (2021) <em>Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial. L</em>ancet Infectious Diseases. <a href=\"https://www.thelancet.com/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"2f29bb61-c379-4a6c-8ab9-acb400ce63d2\">www.thelancet.com</a> [<a href=\"https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30600-9/fulltext\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"41839bd4-945c-44d3-9ccf-acb400ce63d2\">Free Full-text</a>]</li></ul><!-- end field 16995ef2-a2fe-47c0-b0ad-b311cd62a8cc --><!-- end item 34042ec6-2ed4-4c7a-a058-d667b68f906c -->","subChapters":[]},{"id":"bc21c7c6-4f3c-57b4-957d-3becf77a194e","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field bd987424-aa69-4a6f-8a18-d8760aeea74d --><h3>New policies</h3><!-- end field bd987424-aa69-4a6f-8a18-d8760aeea74d -->","summary":null,"htmlStringContent":"<!-- begin item e7c8b15e-b2fa-4d68-b540-718a00557eae --><!-- begin field b8a5cbd8-1462-4563-9a64-6e24dc9b411b --><p>No new national policies or guidelines since 1 June 2016.</p><!-- end field b8a5cbd8-1462-4563-9a64-6e24dc9b411b --><!-- end item e7c8b15e-b2fa-4d68-b540-718a00557eae -->","subChapters":[]},{"id":"d111576b-54a8-5d61-998d-f16ec2f33659","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field 38b1d808-5d31-4d7b-8d03-ab7b54cb0f80 --><h3>New safety alerts</h3><!-- end field 38b1d808-5d31-4d7b-8d03-ab7b54cb0f80 -->","summary":null,"htmlStringContent":"<!-- begin item d0c31ab4-6d16-421f-87da-f032ea0af4ab --><!-- begin field 465ea0b9-b869-4fde-963f-f25263b4d2ee --><p>No new safety alerts since 1 June 2016.</p><!-- end field 465ea0b9-b869-4fde-963f-f25263b4d2ee --><!-- end item d0c31ab4-6d16-421f-87da-f032ea0af4ab -->","subChapters":[]},{"id":"0b57d04d-710e-56d3-8799-d197abbf15a3","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field f8d9cb0c-08fc-487c-a66e-5b2034474d14 --><h3>Changes in product availability</h3><!-- end field f8d9cb0c-08fc-487c-a66e-5b2034474d14 -->","summary":null,"htmlStringContent":"<!-- begin item 7f0743bd-fe90-4113-af5b-bd4fed35acbb --><!-- begin field 5ab54b77-4afb-4ba3-a057-9f9d5fac80eb --><ul><li>New product available: Trumenba (Meningococcal group B vaccine [recombinant, adsorbed]). See: <a href=\"http://www.medicines.org.uk/emc/medicine/33454\" data-hyperlink-id=\"dcadd2e4-da1f-486d-96e5-a8f7015427ec\">Summary of product characteristics</a>.</li><li>New product available: Infanrix hexa Powder and suspension for suspension for injection. Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and <em>Haemophilus influenzae </em>type b (Hib) conjugate vaccine (adsorbed). See:<a href=\"https://www.medicines.org.uk/emc/medicine/33313\" data-hyperlink-id=\"4dc6e219-9b5d-45b2-aad5-a8f701542865\"> Summary of product characteristics.</a></li></ul><!-- end field 5ab54b77-4afb-4ba3-a057-9f9d5fac80eb --><!-- end item 7f0743bd-fe90-4113-af5b-bd4fed35acbb -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}